-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVARTIS RECEIVES HEALTH CANADA APPROVAL FOR (PR)RHAPSIDO® (REMIBRUTINIB TABLETS) ORAL TREATMENT FOR ADULTS WITH CSU

Reuters·07/27/2026 19:19:55

Please log in to view news